Back
Inspire 500 ETF Vs. Kymera Therapeutics Industry Stock Comparison
Buy
60
PTL
Inspire 500 ETF
Last Price:
217.83
Seasonality Move:
--
Buy
71
KYMR
Kymera Therapeutics
Last Price:
46.27
Seasonality Move:
65.72%
Buy
60
Inspire 500 ETF (PTL)
is a Buy
Is Inspire 500 ETF a Buy, Sell or Hold?
- The current Inspire 500 ETF [PTL] share price is $217.86. The Score for PTL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- PTL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTL Stock Price Chart
What is Inspire 500 ETF's stock price today?
-
The Inspire 500 ETF share price today is $217.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTL is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.56 | Buy |
Relative Strength Index (14 RSI): | 64.31 | Buy |
Chaikin Money Flow: | 2616 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (210.05 - 215.91) | Buy |
Bollinger Bands (100): | (197.59 - 210.43) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 59.12 | Buy |
Chaikin Money Flow: | 317205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.81 - 49.49) | Buy |
Bollinger Bands (100): | (34.86 - 47.92) | Buy |
PTL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 215.93 | Buy |
20-day SMA: | 214.11 | Buy |
50-day SMA: | 208.42 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 216.21 | Buy |
20-day EMA: | 213.83 | Buy |
50-day EMA: | 209.63 | Buy |
200-day EMA: | 29.9 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.58 | Buy |
20-day SMA: | 46.67 | Buy |
50-day SMA: | 46.11 | Buy |
200-day SMA: | 38.62 | Buy |
8-day EMA: | 45.67 | Buy |
20-day EMA: | 45.85 | Buy |
50-day EMA: | 45.2 | Buy |
200-day EMA: | 38.5 | Buy |
Inspire 500 ETF Earnings Growth & PTL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Inspire 500 ETF Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |